Physiological levels of chromogranin A prevent doxorubicin‐induced cardiotoxicity without impairing its anticancer activity-Reference-Cited by-同舟云学术

Physiological levels of chromogranin A prevent doxorubicin‐induced cardiotoxicity without impairing its anticancer activity

Published:2019-04-11 Issue:6 Volume:33 Page:7734-7747
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Rocca Carmine¹,Scavello Francesco¹,Colombo Barbara²,Gasparri Anna Maria²,Dallatomasina Alice²,Granieri Maria Concetta¹,Amelio Daniela¹,Pasqua Teresa¹,Cerra Maria Carmela¹³,Tota Bruno¹³,Corti Angelo²,Angelone Tommaso¹³

Affiliation:

1. Laboratory of Cellular and Molecular Cardiac PathophysiologyDepartment of Biology, Ecology, and Earth ScienceUniversity of CalabriaRende (Cosenza)Italy

2. Division of Experimental OncologyVita-Salute San Raffaele UniversityIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific InstituteMilanItaly

3. National Institute of Cardiovascular Research (INRC)BolognaItaly

Funder

Ministero dell’Istruzione, dell’Università e della Ricerca

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201802707R

Reference61 articles.

1. Anthracycline Cardiotoxicity: From Bench to Bedside